Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why Chimerix Inc. Shares Jumped

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Chimerix (NASDAQ: CMRX  ) , a clinical-stage biopharmaceutical company focused on developing antiviral therapeutics, popped as much as 10% after reporting its third-quarter earnings results.

So what: For the quarter, Chimerix's revenue decreased to $0.9 million from $20.9 million in the year-ago period primarily due to one-time milestone payments received last year. The company also turned in a quarterly loss of $6.7 million, or $0.26 per share, compared to an adjusted profit of $0.11 per share last year. However, this loss was $0.13 narrower than Wall Street had expected. Chimerix also recapped its pipeline progress, which includes the initiation of a late-stage trial involving brincidofovir for the prevention of CMV in patients receiving bone marrow transplants.

Now what: Any time a clinical-stage biotech company winds up losing less money than expected, it's good news for shareholders as it means the cash burn rate is likely lessening. I would, however, suggest not getting too wrapped up in Chimerix's move higher today until we get a better idea of how its brincidofovir late-stage data looks. I often get criticized for missing the big moves in biotech stocks for taking the conservative approach, but I also tend to avoid those calamitous 50%+ down days by playing it safe. I would certainly suggest the conservative approach may be your best bet with Chimerix.

You don't have to wait with this growth stock
Although Chimerix may offer a lot of promise, you don't have to wait to check out this incredible tech stock -- which is growing twice as fast as Google and Facebook, and more than three times as fast as and Apple. Watch our jaw-dropping investor alert video today to find out why The Motley Fool's chief technology officer is putting $117,238 of his own money on the table, and why he's so confident this company will be a huge winner in 2013 and beyond. Just click here to watch!

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2727113, ~/Articles/ArticleHandler.aspx, 9/27/2016 4:41:30 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,228.30 133.47 0.74%
S&P 500 2,159.93 13.83 0.64%
NASD 5,305.71 48.22 0.92%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 4:00 PM
CMRX $5.77 Up +0.17 +3.04%
Chimerix CAPS Rating: ***